QUICK LINKS
Roxithromycin-d7 is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. This binding interferes with the translocation step of protein synthesis, leading to the inhibition of peptide bond formation and ultimately preventing the elongation of the polypeptide chain. By disrupting this cellular process, Roxithromycin-d7 effectively halts the growth and proliferation of susceptible bacteria. Roxithromycin-D7′s mechanism of action involves targeting the bacterial ribosome, thereby disrupting the synthesis of proteins required for bacterial survival. This interference with protein synthesis ultimately leads to the bactericidal or bacteriostatic effects observed in experimental applications.
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Roxithromycin-d7, 1 mg | sc-472797 | 1 mg | $301.00 |